Transformation of residual mature ovarian teratoma to adenocarcinoma 10 years after initial treatment

Clinical Oncology

Volumn 8, Issue 2, 1996, Pages 125-126

  Ahmed, F Y ^a,b   Gore, M E ^a   Shepherd, J ^a   Fisher, C ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Adenocarcinoma; Malignancy; Ovarian teratoma; Secondary

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LAPAROTOMY; MALIGNANT TRANSFORMATION; OVARY ADENOCARCINOMA; OVARY TERATOMA; PRIORITY JOURNAL;

EID: 0029969355     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0936-6555(96)80122-1     Document Type: Article

References (5)

1. Young RC, Perez CA, Hoskins WJ. Cancer of the ovary. In: De Vitra VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and practice of oncology, 4th ed. Philadelphia, PA: Lippincott, 1993:1255.
2. Ulbright TM, Loehrer PJ, Roth LM, et al. The development of non germ cell malignancies within germ cell tumours? A clinicopathiological study of 11 cases. Cancer 1984;54:1814-33.
3. Borge N, Fossa SD, Ous S, et al. Late recurrence of testicular cancer. J Clin Oncol 1986;6:1248-55.
4. Jurnean HG, Komorowski R, Mahvi D, et al. Immature teratoma of the ovary: An unusual case. Gynecol Oncol 1992;46:111-4.
5. Molenaar WM, Oosterhuis JW, Meiring A, et al. Histology and DNA contents of a secondary malignancy arising in a mature residual lesion six years after chemotherapy for disseminated nonseminomatous testicular tumour. Cancer 1986;58:264-68.